Robert Peter Kadlec - 02 Sep 2025 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
Issuer symbol
INKT
Transactions as of
02 Sep 2025
Transactions value $
$13,514
Form type
4
Filing time
03 Sep 2025, 17:30:44 UTC
Previous filing
04 Jun 2025
Next filing
11 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kadlec Robert Peter Director 149 FIFTH AVENUE, SUITE 500, NEW YORK By: /s/ Christine Klaskin, Attorney-in-Fact 03 Sep 2025 0002047073

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Award $13.5K +975 +5.76% $13.86 17.9K 02 Sep 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.